AN2 Therapeutics (ANTX) Proxy Filing summary

Executive summary

• Annual meeting scheduled for May 22, 2025, at the Menlo Park, California office.

• Stockholders of record as of March 24, 2025, are eligible to vote.

• Proxy materials, including the Notice, Proxy Statement, and Annual Report, are available online and by request.

Voting matters and shareholder proposals

• Election of three Class III director nominees to serve until the 2028 annual meeting or until successors are appointed.

• Ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.

• Named Proxies authorized to vote on other business properly brought before the meeting.

Board of directors and corporate governance

• Board recommends voting "FOR" all director nominees and the auditor ratification proposal.

• Director nominees are Eric Easom, Stephanie Wong, and Joseph Zakrzewski.